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Background: Antibiotic resistance has been referred to as ‘the greatest malice of the 21st century’ and a global action
plan was adopted by the World Health Assembly in 2015. There is a wealth of independent studies regarding
antibiotics and resistant bacteria in humans, animals and their environment, however, integrated studies are lacking,
particularly ones that simultaneously also take into consideration the health related behaviour of participants and
healthcare providers. Such, ‘One health’ studies are difficult to implement, because of the complex teamwork that they
entail. This paper describes the protocol of a study that investigates ‘One health’ issues regarding antibiotic use and
antibiotic resistance in children and their environment in Indian villages.
Methods/Design: Both quantitative and qualitative studies are planned for a cohort of children, from 6 villages, and
their surrounding environment. Repeated or continues data collection is planned over 2 years for quantitative studies.
Qualitative studies will be conducted once. Studies include parents’ health seeking behavior for their children (1–3 years
of age at the onset), prescribing pattern of formal and informal healthcare providers, analysis of phenotypic antibiotic
resistance of Escherichia coli from samples of stool from children and village animals, household drinking water, village
source water and waste water, and investigation on molecular mechanisms governing resistance. Analysis of
interrelationship of these with each other will also be done as basis for future interventions. Ethics approval has been
obtained from the Institutional Ethics Committee R.D. Gardi Medical College, Ujjain, India (No: 2013/07/17-311).
Discussion: The findings of the study presented in this protocol will add to our knowledge about the multi-factorial
nature of causes governing antibiotic use and antibiotic resistance from a ‘One health’ perspective. Our study will be the
first of its kind addressing antibiotic use and resistance issues related to children in a One-health approach, particularly
for rural India.
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Antibiotic resistance (ABR) is a major global public health
problem, which has attracted considerable attention and
research efforts in the recent past [1]. The factors associ-
ated with the global rise in ABR are multi-factorial and
thus require multi-pronged strategies to prevent further
development and spread of resistance [1, 2]. WHO
emphasizes in the ‘Global Action Plan on Antimicrobial
Resistance’ published in 2015 the need for a ‘Whole-of-so-
ciety engagement including a one-health approach’
especially when it comes to antibiotic resistance [2]. The
realization of the multi-factorial nature of causes govern-
ing antibiotic use and ABR has brought into focus the
need for an integrated approach to study the problem in
its entirety and points to the necessity to devise compre-
hensive interventions addressing multi-factorial issues -
the ‘One health’ approach. ‘One health’ is defined as “the
collaborative multi-disciplinary team-working locally,
nationally, and globally — to attain optimal health for
people, animals and the environment” [3]. However, as
‘One health’ is a rather new concept and as ‘One health’
studies entails an exhaustive complex teamwork, they are
not common. Thus, to get a comprehensive picture of
antibiotic use and resistance in a community, we need to
study human behavior, (in the context of health seeking
and prescribing) in their natural ecosystem including
surrounding animals, source water in their geographical
location, household drinking water and waste water.
All antibiotic use, especially irrational use like overuse
is since long one of the major concern for development
and spread of ABR in humans [4]. There have however
been a limited number of studies aiming to identify
context specific barriers and facilitators for appropriate
clinical management of infectious diseases in lower-
middle income countries like India. Identifying barriers
and facilitators is a major challenge in designing and
implementing successful interventions in general and for
child health in particular [5]. There is need to document
the current prescribing patterns along with knowledge
and attitudes in relation to treatment of common infec-
tious aetiologies by health care practitioners on one
hand and also to understand the community health
seeking behaviour on the other hand in order to limit
the spread of ABR [6].
Apart from fundamental applications in preventing
and treating infections in humans, antibiotics are used
e.g. in agriculture [7]. Due to incomplete metabolism of
ingested antibiotics or disposal of unused antibiotics,
antibiotics enter the environment [8]. In environment,
antibiotic residues might induce the development of
ABR genes in the bacteria [8]. There is worldwide
concern about emergence of ABR in bacteria carried by
healthy individuals and in individuals in the community
treated with antibiotics [9]. Commensal bacteria of thegut may play a crucial role in the spread of resistance
within a community as faecal flora act as a reservoir of
ABR genes [9]. Exposure of commensals such as Escheri-
chia coli to antibiotics increases the carriage level of resist-
ant bacteria by healthy humans and resistance might then
also be transmitted to more virulent bacteria [9]. E. coli of
animal, humans and environmental origin including that
from water sources serve as natural habitats for ABR genes
[8, 10]. As mentioned above, antibiotic residues in the en-
vironment not only alter the ecology of the environment
but also give rise to selection of ABR [8]. It has also been
found that the biophysical and socio-behavioral environ-
ment e.g. prescriber behavior and attitudes modifies anti-
biotic use and ABR [11, 12].
Since, there has been no major comprehensive study
initiated in a lower-middle income country involving
humans, animals, and their natural ecosystems and
linking the socio-behavioral aspects of healthcare pro-
viders and health care seekers, with it, our research
team initiated a trans-disciplinary ‘One health’ study
with the following objectives:
a) To determine, over a period of two years, patterns of
health seeking behavior of parents for their children
aged between 1 and 3 years in a cohort.
b) Surveillance of antibiotic prescription pattern for
common childhood illnesses by formal and informal
health care providers (IHCPs) in the general area of
the cohort of children between 1 and 3 years of age
as mentioned in a).
c) To explore reasons for and factors influencing antibiotic
prescribing by formal and IHCPs for common
childhood illnesses, including infectious diseases.
d) To identify the pattern and epidemiological
determinants of antibiotic resistance in E. coli
isolated from stools of children between 1 and
3 years of age from the cohort of children as
mentioned in a) and E. coli from drinking water in
the same households and further from animals
(stool) and aquatic environment (source water like
wells/tube-wells/bore-wells, and waste water in
included villages) over a period of two years.
e) To establish the association if any, between
determinants influencing health-seeking behavior of
caregivers’, prescription pattern of healthcare providers
and antibiotic resistance pattern of E. coli isolates from
stools of children.
f ) To determine antibiotic resistance pattern over time
between E. coli isolated; from children, household
drinking water, source water, animals and waste
water samples.
g) To evaluate genomic commonality and diversity
and pan-genomic correlates of ABR genes of E. coli
isolated from human, animal and water samples.
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Design and setting
Design
This is the protocol of a prospective cohort study using
mixed methods with data collection over a two year period.
Setting
The study will be conducted in Ujjain District in the
state of Madhya Pradesh (MP), India. MP has a low
Human Development Index (HDI) score of 0.45 [13]. It
is the second largest state in India with almost 75 % of
its population living in rural areas [14]. Specifically, the
studies will be carried out in the rural Demographic
Surveillance Site (DSS) of R.D. Gardi Medical College
(RDGMC), Ujjain which caters to 60 villages in three
development blocks (Fig. 1).
The population of these villages ranges from 800 to
2500 and approximately 50 % of the villages have a
population of below 1000. Most (80 %) of the healthcare
providers in the DSS (both formal and informal) are
concentrated in one village, hereafter referred to as ‘central
village’ and very few practice from any other village. TheFig. 1 Geographical location of the six included villages. The maps show c
surveillance site (DSS) respectivelystudy area has distinct seasons viz. summer, monsoon, post
monsoon and winter. The summer season (March to June)
is very hot with average maximum temperatures ranging
between 35 and 40 °C, while the monsoon season (late
June to September) witnesses an average of 172 mm rain-
fall, with average maximum temperatures ranging between
29 and 31 °C. The post monsoon season/winter season
(October to February) has average maximum temperatures
ranging between 27 and 31 °C.
Selection of included villages
Since the central village had the maximum concentration
of health care providers (Fig. 1) and as we are studying
health seeking behavior of care givers as well as prescrib-
ing behavior of healthcare providers, we created a 5 km
zone around the central village and enlisted all the villages
within the zone. For further selection, villages with a
population of at least 500 inhabitants and at least 15
children available in the desired age range were listed. It
was also required to have a transport time of less than
45 min from each village to the central microbiology
laboratory at RDGMC. Thus, six villages lying in variouslockwise, India, Madhya Pradesh, Ujjain district and Palwa demographic
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village were selected for the study, three villages
having population > =999 and three villages having
population up-to 998.
Study participants
To select the study participants, a baseline survey and
line listing of the households was conducted in the six
selected villages by trained research assistants. A three
digit number code is allotted to each household in the
selected villages. Members in the line-listed households
are identified and their demographic characteristics
(head of the household, age, sex) are recorded in the
basic survey form (Table 1). Individual identification
number is given to each person in the village. Then all
households with children between 1 and 3 years of age
with further criteria of residing in the village for the past
one year, planning to continue to live in the same village
for the coming three years and willing to participate in
our study are listed. This list of households with children
constitutes our sampling frame. Simple random sam-
pling using random number tables is then used to select
one child in the correct age per household to get the
final list of children from the sampling frame. If more
than one child in the specified age range is present in a
household, the youngest one is included.
Sample size calculation
Estimates of proportions from a single batch of 100
observations e.g. children (but equally applicable to pre-
scriptions or other observations) have a precision of +/-
10%. Using repeated batches of 100 children each (every
four months per year) has 80 % power to detect a linear
trend in any observation in proportion of 0.1 per time
unit (step between batches, negative or positive). The
number of children included in the cohort will be
increased to 110 to accommodate for possible attritionTable 1 Forms used for collection for epidemiological information i
Form no Form name Sample
E-00 Line listing form Universe (n = 6
E-01 Basic survey form Universe (n = 6
E-02 Baseline form (SES form) Universe (n = 6
E-03 New Unique ID Sample (n = 11
E-04a Human and animal stool and water and
waste water sample collection form
Sample (n = 11
E-05 Providers prescription form ——
E-06a Health Seeking (Follow up page) Sample (n = 11
E-06b Health Seeking (Diary) Sample (n = 11over time. This sample size gives a sufficiently high
precision in estimates and at least a 80 % power in
comparisons between data points.
Ethics approval and ethical considerations
Ethics approval has been obtained from the Institutional
Ethics Committee R.D. Gardi Medical College, Ujjain,
India (No: 2013/07/17-311).
Before any type of data collection begins, oral and
written information in the local language, Hindi, is given.
The aim of the study is explained to the participants or
caregivers (parents/guardians), information is given that
confidentiality will be guaranteed from the researchers
and a consent form is signed. In the case where partici-
pants are children, parental/guardian written consent will
be obtained. For interviews and focus group discussions
permission will be obtained for recording. In case any
child needs medical attention the child will be re-
ferred to health facilities run in collaboration with the
medical college.
Pilot study
A pilot study was conducted to field test the data collec-
tion instruments and procedures and to train the research
assistants. Minor changes in the data collection proce-
dures were done after the pilot study.
Data collection methods and laboratory methods
Household survey
A standardized household questionnaire, called Baseline
form (Table 1) is used to survey all the households in
the selected six villages (total 1093 households). The
questionnaire enables the gathering of socio-economic
background information of each household. This back-
ground information will be linked with information
obtained from the other sub-studies.n a ‘One health’ study in Ujjain, India
Description
villages) Enumeration of households and identification
of head of the household
villages) Demographic details of all the members in six villages
for the identification of children for study cohort
villages) Socio- economic details of all households in six villages
identified during line listing
0) Unique identification allotted children in study cohort
0) Forms for filling information during sample collection
(Human, animal and water)
Forms for Surveillance of drug (including antibiotics) by
health providers in study area
0) Follow up page to record sickness found among family
members of study cohort
0) To record detail of health seeking by sick family members
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behaviour of healthcare providers
These sub-studies will focus on determining the patterns
of health seeking behaviour (HSB) in the community, de-
veloping an understanding of interrelationship by analys-
ing associations between factors that influence the HSB of
caregivers for their children and ABR and the antibiotic
prescribing practices of providers including formal as well
as informal health care providers (IHCPs) in a rural
community. GIS mapping of the households and formal
and informal HCP will be done. GIS networks of health
seeking routes will be mapped and analyzed.Health seeking behavior for childhood illnesses
Quantitative survey: A questionnaire to be delivered in
interview form is developed to record: the history of
illness, whether or not any sort of treatment was given
to the child, the child’s routes through the health care
system and the reason for that route. The health seeking
behaviour for the children will be followed every alternate
day for two years by a team of study assistants along with
trained health care workers. Drug use focusing on anti-
biotic use for infectious diseases will be an additional
focus for this survey.
Qualitative methods: Qualitative exploratory interviews
and Focus Group Discussions (FGD) will be done to
ascertain the parent’s or caregiver’s perception of health
seeking for childhood illness and antibiotic use in children
between 1 and 3 years of age. The focus is to explore the
knowledge, understanding, and perceptions of primary
caregivers and their influence in decision making with
respect to treatment seeking for common childhood
illnesses and antibiotic use. A purposive sample of 15–20
caregivers of children between 1 to 3 years of age, with a
variation in background factors like age, educational level
and experience in caring for children, will be selected. The
interviews will be conducted to explore the caregivers’ ex-
periences during an episode of childhood illness and the
reasons behind their actions, the problems they face, their
beliefs, their perceptions about common childhood ill-
nesses and antibiotic use and their opinions for improve-
ment. Further, FGDs will be conducted with at least six
groups of caregivers with various background characteris-
tics, see above, within the study setting [15]. In each FGD
6–8 participants will be included. The FGDs will focus on
exploring variations in ways how the caregivers respond
to common childhood problems and how they see various
options for health seeking. A guideline (with prompts) will
be developed to follow the process; relevant probing will
be used and all questions will be open ended [15]. Facilita-
tors will conduct the interviews and FGDs in Hindi. The
recordings from both the individual interviews and the
FGDs will be transcribed by study assistants in Hindi.Health care provider’s prescriptions for common
childhood illnesses Quantitative survey: Surveillance of
antibiotic prescriptions by formal and informal HCPs
(IHCPs) will be done. Data will be collected monthly for
one year by giving the HCPs a specially designed prescrip-
tion pad to collect their prescriptions in duplicate. The
HCPs will be asked to write in the prescriptions in the spe-
cially designed prescription pad while prescribing to outpa-
tients on their routine outpatient days. Prescriptions will
be collected for the first two weeks or for the first 100 pre-
scriptions every month. The prescription pad will have 200
leaflets. Thus, each pad will have capacity to collect 100
prescriptions per month in duplicate, one for the HCP and
one for the research assistant. The prescription pads will
be replaced with new prescription pads at the end of each
month. Qualitative methods: To understand the reasons of
the prescribing pattern especially of antibiotics for com-
mon illnesses in children, individual interviews will be con-
ducted with 15–20 formal and informal HCPs. Open-
ended questions will be used to explore perceptions about
antibiotic use, resistance, its consequences and the factors
driving this action; 2) FGDs will be conducted separately
with different types of HCPs. The FGDs will be done by
first presenting different case scenarios of commonly en-
countered medical conditions in children, and rating the
individual responses as correct or incorrect on the basis of
whether or not the antibiotic prescription given in the
scenario was deemed necessary and then the FGD partici-
pant’s perception of giving this prescription in that particu-
lar scenario will be explored by starting a discussion using
a topic guide. Six to eight participants will be included in
each FGD and at least 6 FGD will be conducted [15]. Par-
ticipants for the FGD will be selected considering gender
variation and type of practitioner i.e. allopathic providers
and IHCP. We will try to obtain knowledge of the different
practitioner’s natural meetings within the district and find
key-persons to help with recruitment. We will try to obtain
homogeneity with respect to type of practitioner (i.e. allo-
pathic provider or IHCP) in the FGDs to avoid missing out
important data due to a hierarchical social system between
different types of health care practitioners.
Sample collection for microbiological analyses
Samples will be collected at six time points during a
2-year period at an interval of four months, three times in
a year in the summer, monsoon and postmonsoon/winter
seasons in order to record changes over time and potential
seasonal effects. An overview of samples included and
laboratory methods are shown in Fig. 2.
Collection of stool samples from children and animals
The collection of stool samples from children and animals
will be performed in the following way and with the
material as described below:
Fig. 2 Overview of sample types included, and laboratory methods, that will be used. WW: Waste water, SDW: Source drinking water, HDW: Household
drinking water, CFU: Colony forming units, E. coli: Escherichia coli, LB-broth: Luria-Bertani broth, PCR: Polymerase Chain Reaction, ABR: Antibiotic resistance,
WGS: Whole Genome Sequencing
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wide mouth plastic container along with a spoon for
transferring the stool to the container; 2) A sterile poly-
ethylene sheet measuring 15x15cm for collecting stool.
The container and polythene sheet to be enclosed in a zip
locked polyethylene bag. b) The stool sampling kit will be
distributed in the households of the selected children one
day prior to the day of sample collection, c) The caregivers
will be trained by the research assistants how to use the
stool sampling kit to collect early morning stool on the
day of sample collection, d) The parents/caregivers will be
re-briefed regarding stool collection procedure at every
time point of sample collection.
Animals: Fresh stool samples from animals will be
collected in a sterile container using spatula with a
precaution to avoid contamination by soil.
Collection of drinking water and wastewater samples
The drinking water, source water and wastewater samples
will be collected in sterilized glass bottles of 1 litre cap-
acity. Each household will be asked to give drinking water
from the vessel where drinking water is stored in thehouse. Source drinking water will be collected from two
common sources of each village and wastewater will be
collected from two discharge sites in each village.
Transport of stool and water samples to the laboratory
Collected samples (stool and water) will be transported to
the microbiology laboratory by the research assistant on
the day of collection. Cold chain will be maintained to keep
a temperature of 4–6 °C. The maximum time for transpor-
tation will be 45 min.
Laboratory methods
1) Microbiological and molecular methods
a) Isolation and confirmation of E. coli
E.coli will be isolated from the following sources:
stools from cohort of children, animal stool samples,
household- and source-drinking water from village and
village waste- water.
The stool samples (human and animal) will be directly
plated on selective (for all coliforms, inhibits other
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coliforms) media HiCrome® Agar (HiMedia laboratories,
Mumbai, India).
The household- and source-drinking water will be
directly subjected to Membrane Filtration Technique
(MFT) while waste-water will undergo sufficient serial
dilution with normal saline (0.9 %) depending on the
visual turbidity [16]. The filtration will be done by using
through 47 mm diameter and 0.45 μm pore size nylon
membrane filters for a minimum of two and half hours
[16, 17]. If less than six E.coli colonies after 24 h of incu-
bation, the original sample will further be filtered once
with lower dilution. Following filtration the membrane
will be placed on HiCrome® Coliform Agar plates incu-
bated at 37 °C for 24 h [17]. The number of colonies of
coliforms and E.coli (identified as blue-violet colonies on
HiCrome® Coliform Agar) will be estimated after consid-
ering the dilution factor of total number of colony form-
ing units (CFU) of coliforms and E. coli per 100 ml of
filtered sample. The number of CFUs per 100 ml of
filtered sample will be estimated for the number of total
coliforms. The number of E. coli (identified as blue-violet
colonies on HiCrome® Coliform Agar) will be counted.
The comparison of CFUs will provide a snapshot of coli-
form load and the relative abundance of other coliforms
over E. coli or vice versa in the samples tested [17].
All the cultured plates will be photographed. A total of
six isolated colonies of E.coli (to get at least five confirmed
E.coli per sample to be able to detect variation) and two
colonies of different coliforms (to store for future study)
will be placed in 3 ml of Luria-Bertani (LB) media [18].
The LB broth will be incubated for 24 h in shaking incu-
bator to get sufficient growth. Thereafter 2 ml of the broth
will be processed for DNA extraction while 1 ml of broth
will be cryo-preserved at -80 °C in 1:1 solution with sterile
autoclaved glycerol [18]. Confirmation of all E.coli isolates
will be done by PCR (see below).
b) Antibiotic susceptibility testing
Antibiotic susceptibility testing (AST) will be performed
by the Kirby-Bauer disc diffusion method. Disc strengths
used will be as recommended by the current Clinical and
Laboratory Standards Institute (CLSI) guidelines [19].
Antibiotics tested will be: ampicillin, ceftriaxone, cefe-
pime, ciprofloxacin, tetracycline, tigecycline, meropenem,
imipenem, gentamicin, amikacin, sulphamethoxazole, co-
trimoxazole, nalidixic acid and nitrofurantoin. The choice
of antibiotics is based on the CLSI guidelines and use of
antibiotics in the study area for the treatment of infections
caused by gram negative coliforms. The diameter of inhib-
ition zones will be measured to the nearest millimeter
independently by two technical experts. If there will be
variation of more than three millimeters between tworeadings, the procedure will be repeated. If any further
discrepancy will be there in zone diameter the susceptibil-
ity pattern will be confirmed by minimum inhibitory
concentration method according to CLSI guidelines. For
calculations, all isolates with intermediate susceptibility
readings will be considered resistant. Results will be re-
corded in the form of mono-resistance (resistance to a sin-
gle antibiotic), co-resistance (resistance to two antibiotics
of same or different groups) and multi-drug resistance
(MDR) (resistance to at least three different antibiotic
classes) [20]. Extended Spectrum Beta-Lactamase (ESBL)
will be detected phenotypically by the combined disc
diffusion method using Muller Hinton agar with cefotax-
ime (30 μg) and cefotaxime/clavulanic acid (30/10 μg) and
ceftazidime (30 μg) and ceftazidime/clavulanic acid
(30/10 μg) according to CLSI guidelines [19].
c) Quality control
Various quality control measures will be taken at each
step of the procedure to ensure laboratory quality check.
The quality controls will be: a) checking of samples from
each batch of all types of prepared media b) confirmation
of sterility of inoculation loops, swabs and micro tips; c)
check of reagents - normal saline and distilled water; d)
checking of laminar flow at the beginning and at the end
of procedures; Reference strains will be; E. coli ATCC
25922 strain for AST; an ESBL-producing K. pneumoniae
ATCC 700603 strain as per CLSI guideline [19].
2) Molecular methods
a) Approach
The confirmation of all E.coli isolates will be done
through PCR based on genus-specific primers and whole
genome re-sequencing will be used for pan-genomic
identification of molecular determinants of observed
antibiotic resistance in E. coli.
b) Procedure
The genomic DNA will be extracted using standard
procedures from pure E.coli isolates and confirmed by
PCR based on genus-specific primers. The confirmed
E.coli isolates per time point will be classified into six
phenotypically different categories based on the suscepti-
bility patterns to the tested antibiotics – purely susceptible
(where the isolate is susceptible to all the fourteen antibi-
otics tested), purely resistant (where the isolate is resistant
to all the fourteen antibiotics tested), purely intermediate
(where the isolate is intermediately susceptible/resistant to
all the fourteen antibiotics tested), any resistance (where
the isolate is resistant to one or more but not all the four-
teen antibiotics tested), any intermediate (where the isolate
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but not all the fourteen antibiotics tested) and mixed
(where the isolate shows a mixed combination suscep-
tible, resistant and intermediately susceptible/resistant
to the fourteen antibiotics tested). The genomic and
plasmid DNA will be extracted and purified using
standard procedures from confirmed and pure E. coli
isolates which exhibit antibiotic resistance and suscep-
tibility, respectively, to the selected antibiotics. DNA
samples from all resistant isolates and from 20 % of
susceptible isolates (as controls) will be subjected to
whole genome sequencing using Ion-proton Technology
[21]. The sequences will be assembled on the reference
genome of E. coli available and the abundance of known
antibiotic resistance genes will be estimated using the
depth of coverage of the sequences assembled on the
known loci of the resistance genes identified in the
reference genome.
c) Quality control
PCR-positive and PCR-negative controls will be
processed in all PCR assays as: a) E. coli ATCC
25922 strain DNA, b) positive PCR product from
previous PCR assay, c) an extraction control (with all
the steps but without any E. coli), (b) a reaction tube
with substitution of distilled water for the test template,
and (c) a sample that previously yielded a negative re-
sult on PCR. In a run, the PCR-negative controls will
be processed first, followed by test samples and then
PCR-positive control. The run will be accepted when
all the PCR controls will be consistent with the
results.Data management and analyses
Data management
Appropriate data software will be prepared according
to the study design and outcome variables. Database
software will be specially designed to ease the data
entry and to link data from all sub-studies. Unique
identifiers and bar codes will be used for sample tra-
cing from the community to the laboratory and also
to determine the sample flow within the laboratory. A
team of senior researcher will supervise data entry. Ten
per cent of data entry will be double checked by senior re-
searchers for quality assurance. Special arrangements will
be made to maintain confidentiality of the personal data.
For qualitative studies FGDs and interviews, the re-
corded material will be stored in a locked location.
Any identity of the interviewee will be removed from
the transcripts before analysis. The data captured
from various sub studies will be transferred to appro-
priate data analysis software.Data analysis
All quantitative data will be analysed using STATA
(StataCorp. College Station, TX, USA) and appropri-
ate spatial GIS software.Data analysis for quantitative epidemiological data
The descriptive analysis of the information provided by
the care givers will provide the perceived distribution of
the disease profile of the area, the patterns of health
service utilisation, the factors affecting the treatment-
seeking pathways including GIS pathways, the distribu-
tion of the care-seeking time (distribution number of
days from the onset of symptoms to the time when the
patient sought treatment from a HCP), the distribution
of the healthcare expenses on the basis of illness, num-
ber of antibiotic treatments by members of the cohort
and sampling frame for the formal and informal HCPs
practicing in the area. Comparisons will be performed
using chi-square tests/Student’s t-test depending on the
variable type. Furthermore, we will study the differences
in the outcome variables using appropriate statistical
methods, like regression models and time series analyses.
When relevant, clustering will be taken into account in
the analyses.Data analysis for quantitative laboratory data The
colony count, PCR results and antibiotic susceptibility
pattern will be analysed and compared for coliform di-
versity and resistance pattern over a period of two years
in: (a) all the stool samples from the cohort of children
particularly with reference to the antibiotic use and differ-
ential proportion of antibiotic susceptibility, (b) household
drinking- water of cohort of children, common drinking
water source, and community waste-water, (c) stool sam-
ples from selected livestock population in-and around-
the household of the selected children.
The generated genotypic data will also be analyzed (a)
to identify the genotypic antibiotic resistance pattern in
the E. coli with reference to chromosomal- and plasmid-
mediated resistance using specific markers of plasmid-
mediated resistance in E. coli, (b) to identify and confirm
of the origin of E. coli isolates in terms of human- or
animal-origin present in the gut of children (using a
species-specific yet undecided primer set/gene target),
(c) to identify and correlate the phylogenetic lineage of
the ABR E. coli isolates and group them according to the
identified phylogenetic groups. This will identify the
predominantly circulating strains of specific phylogen-
etic clan in the study setting, (d) to follow, compare,
and correlate the coliform diversity pattern, resistance
pattern, and genetic pattern in all the human and en-
vironmental samples.
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tative data will be linked together to get the overall ‘One
health’ model where associations between illness pat-
terns, health seeking behavior, prescribing and resistance
from different sources (humans, animal and water) will
be linked together and followed over time.
Data analysis for qualitative data Appropriate data
analysis method will be used for ordering and synthesising
data [15, 22]. Manifest and latent content analyses will be
used for the analyses [22].
Discussion
To our knowledge this is a unique study protocol in that
it plans to study the diverse and complex problem of
antibiotic use and resistance utilizing both quantitative
and qualitative research methods using a ‘One health’
approach [3]. The ‘One health’ approach has gained
importance in public health in recent times. However, it
has so far contributed very little in solving the major
global health problems [23], as one of the greatest chal-
lenges faced in ‘One health’ studies is that the implemen-
tation of the studies requires collaborative efforts from
experts of multiple disciplines working together in a
trans-disciplinary way.
One strength of this protocol is that the research team
has diverse background expertise ranging from public
health, epidemiology, pharmaco-epidemiology, pharma-
cology, medicine, pediatrics, infectious disease, environ-
mental medicine, agriculture, limnology, general and
molecular microbiology and many of the researchers are
familiar with both qualitative and quantitative method-
ology. The research group also has extensive experience of
working together as evident from previous publications
presented below.
We have earlier reported high proportion of antibiotic
use for common infections among outpatients [24] and
among admitted patients with a suspected focus of in-
fections [25, 26]. High rate of antibiotic prescribing has
been noted in surgical ward [25, 27], in peri-partum
period [28] and in patients admitted in medical intensive
care unit [29]. Inappropriate choice of antibiotics and
also inappropriately long duration of antibiotic therapy
for post-surgery prophylaxis has been documented [25].
High proportion of antibiotic resistance was documented
in pathogens isolated from patients with suspected bacter-
ial infections [30]. Further, resistant E. coli were isolated
from hospital wastewater along with antibiotic residues
[31–33]. High proportion of ABR was also found in com-
mensal E. coli among asymptomatic pregnant women [34],
post-menopausal women [35] and among healthy children
[36]. ESBL-encoding genes, blaCTX-M-15 and blaTEM-1,
and plasmid-mediated quinolone resistance genes, aac
(6′)-Ib-cr, qnrA, qnrB and qepA, were detected form bothpregnant women and healthy children [34, 36]. Our
research group has also earlier demonstrated high ABR in
E. coli isolated from cow’s stool in two geographically
distinct rural areas [37, 38].
It was further found in one of our qualitative studies
that people perceive that change in climate and climatic
factors are associated with antibiotic resistance [39].
Presence of ABR bacteria was also detected in drinking
water sources of rural areas and it was speculated that
this could have been due to surface water runoff from
human and/or animal fecal sources [37]. A nascent idea
of the ‘One health’ approach was proposed in 2008 by
one of our team members calling it ‘Location Specific
Integrated Antibiotic Resistance management Strategy-
LIARMS [40], and in another instance formulating it as
‘Augmented antibiotic stewardship programme’ [41].
We have earlier addressed that that behavior change in
relation to antibiotics is complex and requires multi-
faceted interventions [12]. The planned studies will link
together resistance in E. coli from humans, animals and
the environment in the same villages with behavior re-
lated to health-seeking and prescribing and thus create
further evidence for inter-related interventions taking
the ‘One-health’ concept in the field of antibiotic use
and resistance into consideration.
For all the study components, the protocol employs
the most appropriate design, based on the research
question. Most of the community based quantitative
studies are set up in a cohort of more than 100 children,
a number that satisfies the statistical requirements. This
cohort will be followed continuously for health-seeking
behaviours and samples of analyses of E.coli from children
and their environment (animals and various types of
water) will be taken every four months for a period of two
years. To our knowledge this is the first ‘One-health’ study
from India simultaneously studying E.coli in humans,
animals and the environment in the same location.
The planned molecular studies include whole genome
sequencing (WGS) that is expected to provide a differential
depth of coverage of genetic map for various known anti-
biotic resistance genes in the isolates from humans, ani-
mals and environment. This, in turn, will identify potential
lead candidate genes to track in the subsequent samples
from different time points. Also, such a comparative map-
ping between pure susceptible strains and resistant strains
may identify novel genetic changes (SNPs/indels/genes/
copy number variations), which could later be attributed to
antibiotic resistance based on bioinformatics prediction of
gene function of hitherto unidentified/unannotated DNA
sequences present in the resistant genomes. The informa-
tion obtained from molecular and genetic analyses will be
used to correlate the possibility of sharing antibiotic resist-
ance gene pools between E. coli and non-E. coli coliforms
sharing the same macro- or micro-environment.
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